McMillan Shakespeare Ltd (ASX: MMS) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
McMillan Shakespeare Limited Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$928.57 million
P/E Ratio
769.23
Dividend Yield
2.52%
Shares Outstanding
77.38 million
Earnings per share
-0.076
Dividend per share
0.64
Year To Date Return
-0.71%
Earnings Yield
0.13%
Franking
100%
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Share Market News
Why the McMillan Shakespeare (ASX:MMS) share price has slipped today
ASX Shares
3 top ASX shares to buy according to WAM
Cheap Shares
3 forgotten ASX stocks left behind in the car sales recovery
Share Market News
McMillan (ASX:MMS) share price on watch today. Here’s why
Cheap Shares
Top brokers just upgraded the ResMed (ASX:RMD) share price and this other ASX stock
Share Market News
McMillan (ASX:MMS) share price edges up on AGM
Share Market News
ASX 200 jumps 2.6%, big 4 banks surge
Share Market News
ASX 200 plunges 3.1%, Afterpay suffers
Dividend Payment History Data provided by Morningstar.
| Ex-Date | Amount | Franking | Type | Payable |
|---|---|---|---|---|
| 11 Mar 2021 | $0.3020 | 100.00% | Interim | 26 Mar 2021 |
| 05 Mar 2020 | $0.3400 | 100.00% | Interim | 20 Mar 2020 |
| 28 Aug 2019 | $0.4000 | 100.00% | Final | 11 Sep 2019 |
| 07 Mar 2019 | $0.3400 | 100.00% | Interim | 22 Mar 2019 |
| 13 Sep 2018 | $0.4000 | 100.00% | Final | 28 Sep 2018 |
| 15 Mar 2018 | $0.3300 | 100.00% | Interim | 29 Mar 2018 |
| 28 Sep 2017 | $0.3500 | 100.00% | Final | 13 Oct 2017 |
| 30 Mar 2017 | $0.3100 | 100.00% | Interim | 13 Apr 2017 |
| 29 Sep 2016 | $0.3400 | 100.00% | Final | 14 Oct 2016 |
| 31 Mar 2016 | $0.2900 | 100.00% | Interim | 15 Apr 2016 |
| 29 Sep 2015 | $0.2700 | 100.00% | 16 Oct 2015 | |
| 30 Mar 2015 | $0.2500 | 100.00% | 17 Apr 2015 | |
| 29 Sep 2014 | $0.3100 | 100.00% | 15 Oct 2014 | |
| 16 Sep 2010 | $0.1400 | 100.00% | Final | 15 Oct 2010 |
MMS ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About McMillan Shakespeare Ltd
McMillan Shakespeare Limited (ASX: MMS) is a market leader in salary packaging, novated leasing, and fleet and asset management services. McMillan provides services to major employers across Australia, New Zealand and the United Kingdom through brands including Maxxia, RemServ, Interleasing and Holden Leasing.
Clients include state and federal governments, hospitals, not-for-profit organisations and private corporations.
From its origins in 1988 when McMillan first pioneered Australia’s salary packaging industry, the company has grown into a global organisation and top 200 ASX-listed company. With more than 1,200 staff, offices and representatives in every Australian state and territory, as well as Auckland and London, McMillan manages more than 290,000 employee benefit programs and more than 70,000 vehicles.
The McMillan share price has been impacted in FY20 as the COVID-19 pandemic sent a wrecking ball through Australia’s workforce. However, the professional services firm is gaining traction with its rapid digital program expansion to service customers remotely.
MMS Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 11 Jun 2021 | $12.00 | $-0.02 | -0.17% | 343,244 | $12.03 | $12.20 | $11.94 |
| 10 Jun 2021 | $12.02 | $0.00 | 0.00% | 182,221 | $11.95 | $12.08 | $11.85 |
| 09 Jun 2021 | $12.02 | $0.02 | 0.17% | 120,433 | $12.21 | $12.21 | $11.93 |
| 08 Jun 2021 | $12.00 | $0.00 | 0.00% | 193,560 | $11.98 | $12.06 | $11.93 |
| 07 Jun 2021 | $12.00 | $0.00 | 0.00% | 47,881 | $12.04 | $12.06 | $11.93 |
| 04 Jun 2021 | $12.00 | $-0.05 | -0.41% | 235,459 | $12.14 | $12.17 | $11.92 |
| 03 Jun 2021 | $12.05 | $-0.16 | -1.31% | 134,488 | $11.67 | $12.21 | $11.67 |
| 02 Jun 2021 | $12.21 | $0.49 | 4.18% | 191,772 | $11.73 | $12.34 | $11.65 |
| 01 Jun 2021 | $11.72 | $0.14 | 1.21% | 59,279 | $11.58 | $11.72 | $11.52 |
| 31 May 2021 | $11.58 | $-0.66 | -5.39% | 93,540 | $12.30 | $12.30 | $11.57 |
| 28 May 2021 | $12.24 | $0.54 | 4.62% | 425,562 | $11.75 | $12.24 | $11.63 |
| 27 May 2021 | $11.70 | $-0.04 | -0.34% | 170,866 | $11.74 | $11.74 | $11.44 |
| 26 May 2021 | $11.74 | $0.40 | 3.53% | 130,269 | $11.34 | $11.77 | $11.31 |
| 25 May 2021 | $11.34 | $0.10 | 0.89% | 66,199 | $11.24 | $11.34 | $11.11 |
| 24 May 2021 | $11.24 | $-0.29 | -2.52% | 155,804 | $11.31 | $11.36 | $11.07 |
| 21 May 2021 | $11.53 | $0.47 | 4.25% | 172,386 | $11.11 | $11.62 | $11.10 |
| 20 May 2021 | $11.06 | $-0.19 | -1.69% | 75,283 | $10.99 | $11.23 | $10.99 |
| 19 May 2021 | $11.25 | $0.15 | 1.35% | 79,454 | $11.05 | $11.32 | $11.00 |
| 18 May 2021 | $11.10 | $-0.02 | -0.18% | 167,737 | $11.14 | $11.16 | $11.03 |
| 17 May 2021 | $11.12 | $0.07 | 0.63% | 53,356 | $11.24 | $11.24 | $11.07 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 25 Mar 2021 | John Bennetts | Sell | 40 | $450,472 |
On-market trade.
|
| 24 Mar 2021 | John Bennetts | Sell | 57 | $639,711 |
On-market trade.
|
| 23 Mar 2021 | John Bennetts | Sell | 11 | $126,784 |
On-market trade.
|
| 22 Mar 2021 | John Bennetts | Sell | 28 | $320,662 |
On-market trade.
|
| 19 Mar 2021 | John Bennetts | Sell | 11 | $137,824 |
On-market trade.
|
| 17 Mar 2021 | John Bennetts | Sell | 25 | $280,221 |
On-market trade.
|
| 16 Mar 2021 | John Bennetts | Sell | 45 | $508,590 |
On-market trade.
|
| 12 Mar 2021 | John Bennetts | Sell | 6 | $76,592 |
On-market trade.
|
| 11 Mar 2021 | John Bennetts | Sell | 50 | $603,730 |
On-market trade.
|
| 25 Feb 2021 | Kathryn Parsons | Buy | 2 | $25,900 |
On-market trade.
|
| 27 Nov 2020 | Michael (Mike) Salisbury | Issued | 103 | $1,221,290 |
Issue of securities. 191,878 - Indeterminate Rights & Performance Rights.
As per announcement on 30/11/2020. |
| 20 Aug 2020 | Kathryn Parsons | Buy | 4 | $42,627 |
On-market trade.
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Timothy Michael Poole | Non-Executive DirectorNon-Executive Chairman | Dec 2013 |
Mr Poole is currently Chairman of Aurizon Holdings Limited and a Non-Executive Director of Reece Limited. Mr Poole was previously an executive of the unlisted infrastructure and private equity manager, Hastings Funds Management (1995 to 2007), including being the Managing Director from 2005. He was formerly a Non-Executive Director of Lifestyle Communities Limited, Newcrest Mining Limited and Japara Healthcare Limited. Mr Poole is considered an independent director under the Company's definition of independence.
|
| Mr Bruce John Akhurst | Non-Executive Director | Apr 2021 |
Mr Akhurst is an experienced executive and director of ASX listed companies with an understanding of digital, technology, consumer and regulated businesses. Mr Akhurst is currently a Non-Executive Director of Vocus Group Limited, Tabcorp Holdings Limited and Paul Ramsay Holdings, Chair of the Peter McCallum Cancer Foundation and Council Member of RMIT University chairing the Technology and Infrastructure Committee. His executive career has included Executive Chair of Adstream, CEO of Sensis, Group MD and General Counsel of Telstra and Partner of Mallesons Stephen Jaques. Mr Akhurst will chair the People, Culture Committee and be a member of the Risk and Compliance Committee of MMS effect from 1 April 2021.
|
| Mr John G Bennetts | Non-Executive Director | Dec 2003 |
Mr Bennetts is an experienced investor and has been the founder and director of many successful Australian companies with businesses in technology, finance and manufacturing. Mr Bennetts is a Non-Executive Director of Sacred Heart Mission and also of Culture is Life. He was a founder of Cellestis Limited and private equity investment firm, Mooroolbark Investments Pty Limited (M-Group). He has also previously provided advisory services to a range of companies in Australia and Asia. Prior to the establishment of the M-Group, he was a Member of the senior executive of the pioneering Australian multinational IT company, Datacraft Limited.
|
| Mr Ross Chessari | Non-Executive Director | Dec 2003 |
Mr Chessari is a founder and director of the investment manager, SciVentures Investments Pty Limited (SciVentures). Prior to founding SciVentures, Mr Chessari was the Managing Director of ANZ Asset Management and the General Manager of ANZ Trustees.
|
| Ms Helen Kurincic | Non-Executive DirectorNon-Executive Chairman | Sep 2018 |
Ms Kurincic is Non-Executive Chair of Integral Diagnostics Limited, Non-Executive Director of Estia Health Limited and HBF Health Limited. Formerly, Ms Kurincic was the Chief Operating Officer and Director of Genesis Care from its earliest inception, creating and developing the first and largest radiation oncology and cardiology business across Australia. She has also formerly held Board roles across the publicly listed, private, not-for-profit and government sectors as well as being the former CEO of Benetas and Heart Care Victoria. Ms Kurincic is a Fellow of the Australian Institute of Company Directors. Ms Kurincic is considered an independent director under the Company's definition of independence.
|
| Mr Michael (Mike) Neil Salisbury | Chief Executive OfficerManaging Director | Oct 2014 |
Mr Salisbury joined MMS as Managing Director of RemServ in April 2008 and was appointed to the position of Chief Executive Officer in October 2014. Before joining the company in April 2008, Mr Salisbury was a Member of the senior management team at AAMI. Mr Salisbury held a management positions within the organisation, including a number of state management roles and the position of Product Manager for Compulsory Third Party Insurance. Mr Salisbury is a Member of the Australian Institute of Company Directors, and is a Director of the National Automotive Leasing & Salary Packaging Association.
|
| Ms Kathryn Parsons | Non-Executive Director | May 2020 |
Ms Parsons is a an experienced senior executive and has finance, accounting and risk management experience across a range of industries locally and internationally. Ms Parsons is a former audit partner at Ernst & Young and has spent time as a partner in the firm's US, UK and Australian practices. During the last five years she was part of the firm's Oceania Assurance Leadership team as the Professional Practice Director with responsibility for assurance quality and risk management in the region. She will join as member of the Risk and Compliance Committee of company effective 22/05/2020.
|
| Mr Ashley Conn | Chief Financial OfficerCompany Secretary | Oct 2020 |
-
|
| Ashley Conn | Chief Financial OfficerCompany Secretary |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| Tt Investments Pty Ltd | 29,006,159 | 12.56% |
| HSBC Custody Nominees (Australia) Limited | 18,349,447 | 7.94% |
| Prudential Nominees Pty Ltd | 13,650,000 | 5.91% |
| Pentagon Financial Services Pty Limited | 13,579,009 | 5.88% |
| National Nominees Limited | 13,219,218 | 5.72% |
| Wyllie Group Pty Ltd | 12,474,576 | 5.40% |
| J P Morgan Nominees Australia Pty Limited | 11,096,604 | 4.80% |
| Pentagon Capital Pty Limited | 9,456,279 | 4.09% |
| Citicorp Nominees Pty Limited | 8,077,895 | 3.49% |
| Tt Investments Pty Limited | 7,236,994 | 3.13% |
| UBS Nominees Pty Ltd | 7,129,989 | 3.08% |
| National Exchange Pty Ltd | 6,400,000 | 2.77% |
| Pentagon Capital Pty Limited I | 4,500,000 | 1.94% |
| Mr Glenn Butterworth | 3,000,000 | 1.29% |
| Mr James Storey | 3,000,000 | 1.29% |
| Mr Tony Pitt | 3,000,000 | 1.29% |
| BNP Paribas Noms (Nz) Ltd | 1,700,684 | 0.73% |
| Gemtrick Pty Ltd | 1,250,000 | 0.54% |
| Cs Fourth Nominees Pty Limited <Hsbc Cust Nom Au Ltd 11 | 1,105,043 | 0.47% |
| Neweconomy Com Au Nominees Pty Limited | 1,066,681 | 0.46% |